Antibody responses to the hepatitis C virus E2 protein: Relationship to viraemia and prevalence in anti-HCV seronegative subjects

Journal of Medical Virology

Volumn 51, Issue 1, 1997, Pages 1-5

  Cerino, Antonella ^a   Bissolati, Morena ^a   Cividini, Agostino ^a   Nicosia, Alfredo ^c,d   Esumi, Mariko ^e   Hayashi, Nakanobu ^e   Mizuno, Kyosuke ^f   Slobbe, Rob ^g   Oudshoorn, Peter ^g   Silini, Enrico ^b   Asti, Margherita ^b   Mondelli, Mario U ^a,c  

^a Ist di Clin delle Malat Infettive   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d IRBM   (Italy)

^e NIHON UNIVERSITY   (Japan)

^f Chemo Sero Therapeutic Research Institute   (Japan)

^g Organon Teknika   (Netherlands)

Author keywords

antibodies; E2; HCV RNA; hepatitis C virus; PCR

Indexed keywords

VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN PURIFICATION; SERODIAGNOSIS; VIREMIA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOASSAY; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN SORTING SIGNALS; RABIES VIRUS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; VIRAL ENVELOPE PROTEINS; VIREMIA;

EID: 19244369511     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199701)51:1<1::AID-JMV1>3.0.CO;2-C     Document Type: Article

References (25)

1. Ahmed M, Shikata T, Esumi M (1996): Murine humoral immune response against recombinant structural proteins of hepatitis C virus distinct from those of patients. Microbiology and Immunology 42:169-176.
2. Alter HJ (1995): To C or not to C: These are the questions. Blood 85:1681-1695.
3. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G (1993): Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933.
4. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH (1992): Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140.
5. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell PH (1994): Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proceedings of the National Academy of Sciences of the USA 91:7792-7796.
6. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shapiro M, Alter HJ, Purcell RH (1995): Prevention of HCV infection in chimpanzees by hyperimmune serum against the hypervariable region 1 (HVR1): Emergence of neutralization escape mutants in vivo. Hepatology 22:220A.
7. Goding JW (1986): Generation of conventional antibodies - preparative SDS-polyacrylamide gel electrophoresis. In Goding JW (ed): "Monoclonal Antibodies Principles and Practice." London: Academic Press, Inc., pp 284-286.
8. Hsu HH, Donets M, Greenberg HB, Feinstone SM (1993): Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology 17:763-771.
9. Inoue Y, Suzuki R, Matsuura Y, Harada S, Chiba J, Watanabe Y, Saito I, Miyamura T (1992): Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases. Journal of General Virology 73:2151-2154.
10. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K (1993): Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. Journal of Virology 67:3923-3930.
11. Kwok S, Higuchi R (1989): Avoiding false positives with PCR. Nature 399:237-238.
12. Mita E, Hajashi N, Ueda K, Kasahara A, Fusamoto H, Takamizawa A, Matsubara K, Okayama H, Kamada T (1992): Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease. Biochemical and Biophysical Research Communications 183:925-930.
13. Mondelli MU (1996): Is there a role for immune responses in the pathogenesis of hepatitis C? Journal of Hepatology, 25:232-238.
14. Nisihara T, Nozaki C, Nakatake H, Hoshiko K, Esumi M, Hayashi N, Hino K, Hamada F, Mizuno K, Shikata T (1993): Secretion and purification of hepatitis C virus NS1 glycoprotein produced by recombinant baculovirus-infected insect cells. Gene 129:207-214.
15. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens I, Chin M, Dong C, Weiner AJ, Lau JYN, Choo QL, Chien D, Pileri P, Houghton M, Abrignani S (1996): A quantitative test to estimate neutralizing antibodies to hepatitis C virus: Cytofluorometric assessment of envelope glycoprotein E2 binding to target cells. Proceedings of the National Academy of Sciences of the USA 93(5):1759-1763.
16. Rumenapf T, Stark R, Meyers G, Thiel HJ (1991): Structural proteins of hog cholera virus expressed by vaccinia virus: Further characterization and induction of protective immunity. Journal of General Virology 65:589-597.
17. Scarselli E, Cerino A, Esposito G, Silini E, Mondelli MU, Traboni C (1995): Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. Journal of Virology 69:4407-4412.
18. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994): Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. Journal of Virology 68:1494-1500.
19. Silini E, Bono F, Cerino A, Piazza V, Solcia E, Mondelli MU (1993): Virological feactures of hepatitis C virus infections in hemodialysis patients. Journal of Clinical Microbiology 31:2913-2917.
20. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, Brugnetti B, Civardi E, Salvaneschi L, Mondelli MU (1995): Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21:285-290.
21. Silini E, Mondelli MU (1995): Significance of hepatitis C virus genotypes. Viral Hepatitis Reviews 1:111-120.
22. Spaete RR, Alexander DA, Rugroden ME, Choo KL, Berger K, Crawford K, Kuo C, Leng S, Lee C, Ralston R, Thudium K, Tung JW, Kuo G, Houghton M (1992): Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188:819-830.
23. Vlak JM, Schouten A, Usmany M, Belsham GJ, Klinge-Roode EC, Maule AJ, van Lent JWM, Zuidema D (1990): Expression of cauliflower mosaic virus gene I using a baculovirus vector based upon the p10 gene and using a novel selection method Virology 179:312-320.
24. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992): Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proceedings of the National Academy of Sciences of the USA 89:3468-3472.
25. Zhang YM, Hayes EP, McCarty TC, Dubois DR, Summers PL, Eckels KE, Chanock RM, Lai CJ (1988): Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. Journal of Virology 62:3027-3031.